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Previous studies have identified two signaling interactions regulating cardiac myogenesis in avians, a hypoblast-derived
signal acting on epiblast and mediated by activin or a related molecule and an endoderm-derived signal acting on mesoderm
and involving BMP-2. In this study, experiments were designed to investigate the temporal relationship between these
signaling events and the potential role of other TGFb superfamily members in regulating early steps of heart muscle
development. We find that while activin or TGFb can potently induce cardiac myogenesis in pregastrula epiblast, they show
no capacity to convert noncardiogenic mesoderm toward a myocardial phenotype. Conversely, BMP-2 or BMP-4, in
combination with FGF-4, can readily induce cardiac myocyte formation in posterior mesoderm, but shows no capacity to
induce cardiac myogenesis in epiblast cells. Activin/TGFb and BMP-2/BMP-4 therefore have distinct and reciprocal
cardiac-inducing capacities that mimic the tissues in which they are expressed, the pregastrula hypoblast and anterior
lateral endoderm, respectively. Experiments with noggin and follistatin provide additional evidence indicating that BMP
signaling lies downstream of an activin/TGFb signal in the cardiac myogenesis pathway. In contrast to the cardiogenic-
inducing capacities of BMP-2/BMP-4 in mesoderm, however, we find that BMP-2 or BMP-4 inhibits cardiac myogenesis
prior to stage 3, demonstrating multiple roles for BMPs in mesoderm induction. These and other published studies suggest
a signaling cascade in which a hypoblast-derived activin/TGFb signal is required prior to and during early stages of
gastrulation, regulated both spatially and temporally by an interplay between BMPs and their antagonists. Later cardiogenic
signals arising from endoderm, and perhaps transiently from ectoderm, and mediated in part by BMPs, act on emerging
mesoderm within cardiogenic regions to activate or enhance expression of cardiogenic genes such as GATA and cNkx family
members, leading to cardiac myocyte differentiation. © 1998 Academic Press
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INTRODUCTION
Cells that contribute to the avian heart are found prior to
gastrulation within the posterior half of the epiblast (Raw-
les, 1943; Hatada and Stern, 1994). These cells involute
early during gastrulation and are found within a broad
region of the primitive streak caudal to Hensen’s node
(Garcia-Martinez and Schoenwolf, 1993). Specification of
premyocardial cells commences while the cells are within
the streak (Yatskievych et al., 1997) and continues through
late gastrulation as mesodermal premyocardial cells mi-
grate out of the streak and form bilateral precardiac regions
on either side of the anterior midline (Gonzalez-Sanchez
and Bader, 1990; Antin et al., 1994; Montgomery et al.,
1994; Gannon and Bader, 1995). Cell migration, along with
flexion and folding of the embryo, brings the presumptive
heart primordia together where they fuse to form the
primitive heart tube, composed of an outer myocardium
and an inner endocardium (DeHaan, 1963a,b; Rosenquist,
1966). Differentiation of cardiac myocytes occurs as the
heart tube forms, such that by the time fusion is completed
the heart is a functional contractile organ.
Many studies have sought to elucidate tissue interactions
required for the induction of myocardial cell lineages. In
amphibians, roles in cardiac lineage specification have been
identified for both the organizer region and the deep dor-
soanterior endoderm (Sater and Jacobson, 1990; Nascone
and Mercola, 1995). In birds, two cell layers have been
shown to possess cardiogenic-inducing capacities, the pre-
gastrula hypoblast (Yatskievych et al., 1997) and the ante-
rior lateral (precardiac) endoderm (Orts-Llorca, 1963; Orts-
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Llorca and Gil, 1965; Schultheiss et al., 1995; Sugi and
Lough, 1995; Yatskievych et al., 1997). Inducing capacities
of these two cell layers are not equivalent, however, as the
hypoblast can potently induce cardiac myogenesis in re-
sponsive epiblast but only weakly in mesodermal cells,
whereas the endoderm can readily convert nonprecardiac
mesoderm to a cardiac phenotype but has no ability to
induce heart development in epiblast cells (Schultheiss et
al., 1995; Yatskievych et al., 1997).
Recent studies have identified molecules that may be
responsible for these inductive signals. Activin mRNA is
present in the chick pregastrula hypoblast (Mitrani et al.,
1990), and activin can substitute for the hypoblast to induce
myocardial cell formation in quail posterior pregastrula
epiblast (Yatskievych et al., 1997). High concentrations of
activin can also induce cardiac myogenesis in the amphib-
ian animal cap assay (Logan and Mohun, 1993). TGFb
proteins have been detected in the marginal zone region of
the chick pregastrula embryo and in some cells of the
hypoblast (Sanders et al., 1993, 1994). Although TGFb have
been shown to induce some mesodermal cell types in
amphibian animal caps (Rosa et al., 1988), the potential role
of TGFb molecules in early steps of cardiac myogenesis in
amniotes has not been examined.
Anterior lateral endoderm secretes a variety of signaling
molecules. Among these, growth factors such as insulin,
insulin-like growth factor II, activin, and fibroblast growth
factors (FGFs) appear to promote survival and replication of
specified premyocardial cells and differentiating myocytes
(Kokan-Moore et al., 1991; Parlow et al., 1991; Sugi et al.,
1993; Sugi and Lough, 1995; Antin et al., 1996; Zhu et al.,
1996), while bone morphogenetic proteins (BMPs) appear to
play an inductive role. At mid- to late gastrula stages,
BMP-4 is expressed in a ring of ectoderm surrounding the
future neural plate that is adjacent to precardiac mesoderm;
by stage 6, precardiac mesoderm is in contact with BMP-2-
expressing anterior lateral endoderm (Schultheiss et al.,
1997; Streit et al., 1998). Localized application of BMP-2 to
the anterior medial region of stage 6 embryos can induce
local mesodermal expression of cNkx2-5 and GATA-4, and
treatment of explanted stage 6 anterior medial (noncardio-
genic) mesendoderm with either BMP-2 or BMP-4 can
induce full cardiac differentiation (Schultheiss et al., 1997;
Andre´e et al., 1998). While BMP-2 alone cannot induce
posterior lateral mesoderm to become cardiogenic, a com-
bination of BMP-2 plus FGF-4 is sufficient to mimic ante-
rior lateral endoderm in converting posterior mesoderm to a
myocardial cell fate (Lough et al., 1996). The ability of
noggin, a natural BMP antagonist, to inhibit differentiation
of premyocardial cells further indicates that BMPs are
required for a late step in the cardiac myogenesis pathway
(Schultheiss et al., 1997).
The findings summarized above suggest that cardiac
myogenesis is regulated by two temporally distinct signal-
ing events, an early signal derived from hypoblast acting on
epiblast and mediated by activin and/or TGFb and a later
endoderm-derived signal acting on mesoderm involving
BMPs. In the present study, experiments were performed to
test this possibility. We find that activin/TGFb and BMP-
2/BMP-4 have distinct and reciprocal cardiac-inducing ca-
pacities that mimic the tissues in which they are expressed,
the pregastrula hypoblast and the anterior lateral endoderm,
respectively. Noggin can block activin-mediated induction
of cardiac myogenesis in epiblast, providing additional
evidence that BMP signaling lies downstream of activin/
TGFb signaling in the cardiac myogenesis pathway. We also
find that BMP-2- or BMP-4 can inhibit cardiac myogenesis
prior to gastrulation, demonstrating multiple roles for BMP-
2/BMP-4 in mesoderm development.
MATERIALS AND METHODS
Embryo Explantation and Culture
Embryos were removed from fertile chick eggs (Gallus domesti-
cus; Rosemary Farms, Santa Maria, CA, or SPAFAS, Inc., Preston,
CT) following 0–24 h of incubation at 37°C in a humidified
incubator and staged according to Eyal-Giladi and Kochav (1976) for
pregastrula stages (XI–XIV) and according to Hamburger and Ham-
ilton (1951) for stages from the beginning of gastrulation (stage 2)
onward. Embryos were removed from the egg, placed in 123 mM
NaCl, and cleaned of adhering yolk using an eyebrow hair brush.
Explantation of stage XI–XIV intact posterior regions or posterior
region epiblast and heart-forming regions of stage 2–6 embryos was
performed as described (Yatskievych et al., 1997). Explants were
transferred to a fibronectin-coated Lab Tek chamber slide (Naper-
ville, IL) and cultured in defined medium (75% DMEM:25%
McCoy’s medium, supplemented with 1027 M dexamethasone and
50 mg/ml gentamycin) in a humidified incubator at 37°C and 7%
CO2 for 72 h, unless otherwise noted.
Growth Factors and Antagonists
Follistatin (National Hormone and Pituitary Program, Bethesda,
MD) was prepared as a 1 mg/ml stock in 0.1 N HOAc and diluted
to working concentrations in defined medium plus 0.25–0.5 mg/ml
bovine serum albumin (BSA; Sigma, St. Louis, MO). Conditioned
medium was harvested from parental CHO cells or CHO cells
stably expressing Xenopus noggin (Smith and Harland, 1992); CHO
lines were kindly provided by R. Harland (University of California,
Berkeley). Noggin-containing or control conditioned media were
each mixed 1:1 with defined medium supplemented with BSA to a
final concentration of 0.25 mg/ml. Human recombinant activin A
(Genentech, South San Francisco, CA, and National Hormone and
Pituitary Program), porcine TGFb-1 (R&D Research, Minneapolis,
MN), human recombinant BMP-2 and BMP-4 (Genetics Institute,
Cambridge, MA), and human recombinant FGF-4 (R&D Research)
were diluted to working concentrations in defined medium plus
0.25–0.5 mg/ml BSA. Solutions of growth factors and antagonists
were prepared immediately prior to use. For some experiments,
BMP and FGF-4 concentrations were chosen to be consistent with
previously published work (Lough et al., 1996).
Immunofluorescence
A detailed study has previously demonstrated that explants from
the posterior region of pregastrula chick or quail embryos, or
pregastrula epiblast treated with activin, give rise to cardiac, but
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not skeletal muscle cells, during the first 72 h of culture
(Yatskievych et al., 1997). These findings enabled to us employ a
rapid immunofluorescence screen using an antibody against
muscle myosin heavy chain to assay for the presence of cardiac
myocytes. For this analysis, explants were fixed in 4% paraformalde-
hyde in phosphate-buffered saline (PBS) for 15 min at room tempera-
ture, then incubated in PBS plus 0.2% Triton X-100 and 0.02%
sodium azide for 30–45 min at room temperature. Explants were
processed for immunofluorescence using anti-LMM (anti-light mero-
myosin; a gift from Howard Holtzer, University of Pennsylvania,
Philadelphia), a fluorescein-conjugated rabbit antibody that is specific
for striated muscle-specific myosin heavy chain isoforms (Antin et al.,
1994), and DAPI (Sigma) as described (Yatskievych et al., 1997).
Explants were scored as positive for cardiac myocytes when contain-
ing at least one cluster of 4 or more brightly fluorescing anti-LMM-
stained cells. Positive explants generally contained 15–200 contiguous
anti-LMM-positive cells arranged in one or more muscular regions.
Myocardial cells within many cultures exhibited spontaneous rhyth-
mic contractions prior to fixation. Statistical analyses were conducted
as pairwise comparisons of proportions using a modified z test with a
pooled estimate of the standard error.
RESULTS
Activin/TGFb and BMP-2/BMP-4 Have Distinct
Cardiogenic-Inductive Capacities Which Mimic the
Pregastrula Hypoblast and the Anterior Lateral
Endoderm, Respectively
To more fully investigate the roles of TGFb family
members in regulating cardiac myogenesis, the abilities of
several growth factors to induce heart muscle development
in either epiblast or noncardiogenic mesoderm were com-
pared. Activin readily induced cardiac myogenesis in chick
posterior region epiblast (Figs. 1A and 2A) (Yatskievych et
al., 1997), but showed no ability to induce heart muscle
cells in noncardiogenic anterior medial mesoderm (Schul-
theiss et al., 1997) or posterior lateral mesoderm (Fig. 2B).
TGFb proteins can induce dorsal mesoderm from Xenopus
animal caps (Rosa et al., 1988). Since TGFb proteins are
present within some cells of the pregastrula hypoblast
(Sanders et al., 1994), the ability of TGFb-1 to substitute for
hypoblast to induce cardiac myogenesis within chick pos-
terior epiblast was also tested. Like activin, TGFb-1 in-
duced the appearance of cardiac myocytes in responsive
epiblast in a dose-dependent manner (Fig. 1B).
Conversely, neither BMP-2 nor BMP-4 was capable of
inducing myocardial cell formation in chick pregastrula
posterior region epiblast at any dose examined (Fig. 1C).
While BMP-2 and BMP-4 were similarly unable to induce
cardiac myogenesis in posterior mesoderm when used
alone, heart muscle cells were potently induced when
posterior mesoderm was challenged with either molecule in
combination with FGF-4 (Fig. 2B) (Lough et al., 1996).
BMP-2 or BMP-4 plus FGF-4 was unable to induce cardiac
myogenesis above control levels in pregastrula posterior
region epiblast (Fig. 2A), and activin plus FGF-4 was unable
to induce cardiac myogenesis in posterior mesoderm (Fig.
2B), indicating that the inability of BMPs to mimic the
inductive capacity of the hypoblast, or of activin to mimic
the inductive capacity of anterior lateral endoderm, is not
due to the lack of a synergistic FGF partner. These findings,
taken together with previous studies, show that activin/
TGFb can induce cardiac myogenesis in epiblast but not in
mesoderm, while BMP-2 or BMP-4, alone or in combination
with FGF-4, can induce cardiac myogenesis in noncardio-
genic mesoderm but not in epiblast.
It is interesting to note that although FGF-4 is incapable
of inducing heart muscle formation in gastrula-stage poste-
rior lateral mesoderm (Fig. 2B) (Lough et al., 1996), it is a
potent inducer of cardiac myogenesis in pregastrula poste-
rior region epiblast (Fig. 2A). Addition of BMP-2 or BMP-4,
however, inhibited the heart muscle-inducing capacity of
FGF-4. Thus, although BMP-2 and BMP-4 are potent induc-
ers of heart muscle in noncardiogenic mesoderm, they can
inhibit cardiac myogenesis in epiblast (see below). The
potential role of FGFs in avian mesoderm induction will be
detailed elsewhere.
Activin and TGFb Can Induce Cardiac Myogenesis
in Epiblast Cells That Are Not Normally Fated to
Form Heart
As shown above (Figs. 1A and 2A) and previously
(Yatskievych et al., 1997), activin and TGFb-1 are potent
inducers of heart muscle cells in posterior region epiblast.
Posterior epiblast contains cells that are fated to form heart
(Hatada and Stern, 1994), however, and thus it is not clear
from these experiments whether activin or TGFb-1 pro-
vides a permissive influence or whether these molecules are
capable of changing the fate of epiblast cells toward a
myocardial phenotype. To address this issue, the ability of
activin or TGFb-1 to induce cardiac myogenesis in epiblast
regions not fated to give rise to heart was investigated.
Explants from the anterior regions of stage XI–XIV embryos
consisting of both epiblast and forming hypoblast, or ante-
rior epiblast alone, failed to form heart muscle cells in
culture (Figs. 3A and 3B) (Yatskievych et al., 1997). In
contrast, anterior epiblast explants treated with activin or
TGFb-1 contained cardiac myocytes in 43 (n 5 14) and 28%
(n 5 18) of cases, respectively (versus 0% for untreated
controls, n 5 20; significant at P , 0.01; Figs. 3C–3F).
Consistent differences in the health or overall number of
cells within treated versus untreated explants were not
observed, suggesting that observed effects were not due to
differences in cell death or proliferation.
Follistatin and Noggin Inhibit Cardiac Myogenesis
To investigate further the involvement of activin and
BMP signaling during cardiac myogenesis, chick pregastrula
posterior region explants were exposed to follistatin or
noggin at progressively later times following explantation.
While follistatin can block both BMP and activin signaling,
noggin is a specific inhibitor of BMP function (Nakamura et
al., 1990; Kogawa et al., 1991; Yamashita et al., 1995;
Piccolo et al., 1996; Zimmerman et al., 1996; Fainsod et al.,
1997). Consistent with previous reports (Schultheiss et al.,
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1997; Yatskievych et al., 1997), explantation of posterior
regions of stage XI–XIV embryos directly into follistatin- or
noggin-containing medium inhibited cardiac myogenesis
(Figs. 4A and 4B). Addition of follistatin or noggin at
progressively later times following explantation resulted in
a gradual reappearance of heart muscle cells, the timing of
which was distinct for each molecule. Whereas follistatin
effectively inhibited cardiac myogenesis only if added prior
to 24 h following explantation, control levels of cardiac
myogenesis in explants exposed to noggin were not ob-
served until treatment was delayed 36 h (Fig. 4A), coinci-
dent with the onset of cardiac myocyte differentiation
(Yatskievych et al., 1997).
To determine whether the differential time course of
sensitivity to follistatin or noggin observed in explant
culture reflects changes occurring in vivo, stage 5 or 6
precardiac region mesendoderm was explanted directly
into noggin- or follistatin-containing medium and as-
sayed for the presence of differentiated cardiac myo-
cytes after 48 h. As shown in Fig. 4B, noggin, but not
follistatin, effectively inhibited cardiac myogenesis in
stage 5 precardiac region explants. By stage 6, noggin had
FIG. 1. Induction of cardiac myogenesis in posterior region epiblast by activin and TGFb1. Posterior region epiblast from stage
XI–XIV chick embryos was cultured in defined medium plus 0.25– 0.5 mg/ml BSA in the presence of increasing amounts of (A) activin,
(B) TGFb-1, or (C) BMP-2 or BMP-4 for 72 h and then scored for the presence of heart muscle cells. Activin and TGFb-1, but not the
BMPs, induced cardiac myogenesis in epiblast in a dose-dependent manner. An asterisk (*) denotes a value significantly different from
control (P , 0.05).
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also lost the ability to block cardiac myocyte differentia-
tion, in agreement with Schultheiss et al. (1997).
Thus, both for posterior pregastrula region explants
and for explants from heart-forming regions of progres-
sively older embryos, noggin inhibited cardiac myogen-
esis at a later stage than follistatin under these assay
conditions.
BMP Signaling Is Required for Activin-Mediated
Induction of Cardiac Myogenesis
To explore the relationship between activin and BMP
signaling during cardiac myogenesis further, we asked
whether noggin could inhibit induction of cardiac myo-
genesis by activin in pregastrula posterior region epiblast.
As shown in Fig. 5, whereas 5 ng/ml activin induced the
appearance of cardiac myocytes in epiblast cultured in
control conditioned medium (40% of treated explants
contained cardiac myocytes, n 5 20, relative to 0% of
cases for untreated controls, n 5 15; significant at P ,
0.005), the presence of noggin efficiently blocked the
ability of activin to induce myocardial cell formation
(only 8% of explants contained cardiac myocytes, n 5 25;
significantly less than activin treatment alone, P , 0.005,
and not significantly different from untreated controls,
P , 0.05). Again, no significant differences were observed
in health or cell number within treated versus untreated
explants, indicating that the observed effects were not
due to gross changes in cell death or proliferation. Taken
with the results showing reciprocal inducing capacities
of activin/TGFb and BMPs, these findings provide addi-
tional strong evidence that inductive BMP signals are
required downstream of activin in the cardiac myogen-
esis pathway.
BMPs Inhibit Cardiac Myogenesis Prior to Stage 3
Results above show that BMP-2 or BMP-4 can inhibit the
ability of FGF-4 to induce cardiac myogenesis in posterior
epiblast (Fig. 2A). To determine whether BMPs could also
inhibit activin induction of heart muscle cells, chick pre-
gastrula posterior region epiblast was explanted into me-
dium containing activin plus BMP-2 or BMP-4. As shown in
Fig. 2A, either BMP-2 or BMP-4 abolished the ability of
activin to induce the appearance of heart muscle cells.
When intact posterior region explants consisting of epiblast
plus hypoblast were cultured in the presence of BMP-2 or
BMP-4, the appearance of differentiated cardiac myocytes
was also inhibited (Fig. 6). Inhibition of cardiac myogenesis
was also observed in posterior region explants following
addition of fetal bovine serum to the culture medium (data
not shown).
To investigate the timing of the BMP inhibitory signal,
intact posterior region explants consisting of epiblast
plus hypoblast were exposed to BMP-2 or BMP-4 at
progressively later times following explantation. Both
BMP-2 and BMP-4 potently inhibited the incidence of
cardiac myogenesis only if added within 12 to 18 h of
incubation (Fig 6A), even though differentiated cardiac
myocytes are not observed until 32–36 h in control
cultures (Yatskievych et al., 1997). To determine if the
FIG. 2. Induction of cardiac myogenesis in mesoderm. (A) Posterior
region epiblast from stage XI–XIV chick blastoderms or (B) posterior
lateral mesoderm from stage 5 chick embryos was explanted into
defined medium plus BSA with 5 ng/ml activin, 100 ng/ml BMP-2,
100 ng/ml BMP-4, or 100 ng/ml FGF-4 either alone or in various
combinations. BMP-2 or BMP-4 in combination with FGF-4 can
induce cardiac myogenesis in posterior lateral mesoderm, but cannot
induce pregastrula epiblast alone or in combination. Activin alone can
induce cardiac myocyte formation in epiblast, but not in mesoderm,
either alone or in combination with FGF-4. Either BMP-2 or BMP-4
can block induction of epiblast by FGF-4 or activin. An asterisk (*)
denotes a value significantly different from control (P , 0.05).
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loss of responsiveness to BMP inhibition reflects changes
occurring in vivo, heart-forming regions from progres-
sively older gastrula stage embryos were explanted di-
rectly into medium containing BMP-2 or BMP-4. Since
the time course in vitro indicated a narrow early win-
dow of sensitivity, the heart-forming region of the
primitive streak of early (stage 2) and mid- (stage 3)
gastrula stage embryos, as well as mesendoderm ex-
plants from late (stage 5) gastrula stage embryos, was
explanted. As shown in Fig. 6B, the sensitivity to BMP
inhibition is lost in the early to midgastrula stages, the
time at which endoderm and mesoderm are first arising
from epiblast cells involuting into the primitive streak.
Collectively, these results indicate that BMP-2 and
BMP-4 can inhibit the ability of activin, FGF-4, or the
hypoblast to induce heart muscle cell development in
epiblast prior to stage 3. After this time, BMPs provide a
positive signal that is required for progression to differ-
entiated myocardium.
DISCUSSION
We have previously described an avian explant assay for
investigating signaling interactions regulating myocardial
cell development (Yatskievych et al., 1997). Using explants
from the posterior region of stage XI–XIV chick and quail
embryos, it was shown that a signal(s) from the hypoblast is
necessary for the appearance of cardiac myocytes, that
activin can substitute for the hypoblast to induce cardiac
myogenesis, and that the inducing capacities of the pregas-
trula hypoblast and late gastrula anterior lateral endoderm
are qualitatively distinct. Several studies have shown that
BMP-2 plays an important role in mediating the cardiac-
inducing capacity of anterior lateral endoderm (Lough et al.,
1996; Schultheiss et al., 1997; Andre´e et al., 1998).
In the present study, we have shown that activin/TGFb
and BMP-2 have distinct and reciprocal inducing capaci-
ties that mimic the cell layers in which they are ex-
pressed, the hypoblast and anterior lateral endoderm,
FIG. 3. Induction of cardiac myogenesis in anterior region epiblast by activin and TGFb-1. Immunofluorescence micrographs showing
explants stained with anti-LMM (A, C, E) and the DNA-binding dye DAPI (B, D, F). Anterior region epiblast from stage XI–XIV chick
embryos was cultured in defined medium plus 0.25–0.5 mg/ml BSA alone (A, B) or in the presence of 5 ng/ml activin (C, D) or 10 ng/ml
TGFb-1 (E, F) for 72 h and then scored for the presence of heart muscle cells.
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respectively. Consistent with these inducing capacities,
timing experiments using noggin and follistatin indicate
that activin/TGFb signaling lies upstream of BMP signal-
ing in the cardiac myogenesis pathway. Additionally, we
find that BMP-2 or BMP-4 can inhibit an early step in
cardiac myogenesis prior to stage 3, showing that BMPs
have an early inhibitory and later inductive role in heart
muscle development.
FIG. 4. Inhibition of cardiac myogenesis by follistatin and noggin. (A) Stage XI–XIV posterior region explants from chick blastoderms were
explanted in control medium. Treatment was initiated at varying times following explantation by replacement of control medium with medium
containing 100 ng/ml follistatin or conditioned medium containing noggin, and the incidence of cardiac myogenesis was determined following
72 h of culture in all cases. (B) Posterior regions from stage XI–XIV pregastrula embryos or anterior lateral (precardiac) mesendoderm from stage
5 gastrula embryos was excised and explanted directly into 100 ng/ml follistatin or conditioned medium containing noggin, cultured for 72 or
48 h, respectively, and assayed for the presence of cardiac myocytes. An asterisk (*) denotes a value significantly different from control (P , 0.05).
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Activin/TGFb Signaling Acts Upstream of BMP
Signaling in the Cardiac Myogenesis Pathway
Several lines of evidence indicate that activin/TGFb
signaling lies upstream of BMP-2/ BMP-4 signaling in the
cardiac myogenesis pathway. First are the reciprocal induc-
ing capacities of hypoblast versus anterior lateral endoderm
and of the ligands that have been localized to each cell layer
(activin/TGFb and BMP-2, respectively). Activin induces
cardiac myogenesis in pregastrula epiblast (Yatskievych et
al., 1997, and this paper), but is unable to induce heart
muscle cells in gastrula-stage anterior lateral mesoderm
(Schultheiss et al., 1997), posterior lateral mesoderm (Fig.
2B) (Lough et al., 1996), or posterior primitive streak
(T.A.Y., A.N.L., and P.B.A., unpublished observations). The
ability of activin to instructively induce cardiac myogenesis
in epiblast, but not in mesoderm derived from epiblast,
mimics the activity of pregastrula hypoblast (Yatskievych
et al., 1997) and is consistent with the localization of
activin b mRNAs to the chick pregastrula hypoblast (Mi-
trani et al., 1990). TGFb proteins have been detected in
scattered cells of the hypoblast and in marginal zone cells of
the pregastrula chick embryo (Sanders et al., 1994), and
TGFb-1 can likewise substitute for the hypoblast to induce
cardiac myogenesis in epiblast. Activin and TGFb also have
similar mesoderm-inducing activities in amphibian assays
(Rosa et al., 1988; Green et al., 1992; Logan and Mohun,
1993) and act through common intracellular transducers,
the Mad proteins. Binding of TGFb or activin to its receptor
triggers phosphorylation and nuclear translocation of
Smad2 in Xenopus and human (Graff et al., 1996; Nakao et
al., 1997), revealing an intersection of their signaling path-
ways downstream of ligand binding. TGFbs have also been
FIG. 5. Requirement for BMP signaling in induction of epiblast by activin. Immunofluorescence micrographs showing explants stained
with anti-LMM (A, C, E) and the DNA-binding dye DAPI (B, D, F). Posterior region epiblast from pregastrula chick embryos was explanted
into control conditioned medium (A, B), control conditioned medium containing 5 ng/ml activin (C, D), or conditioned medium containing
noggin plus 5 ng/ml activin (E, F), cultured for 72 h, and assayed for the presence of cardiac myocytes. Noggin blocks the ability of activin
to induce myocardial cell formation in epiblast.
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shown to modulate levels of activin mRNA expression in
cultured embryonal cells (van der Kruijssen et al., 1993). It
is therefore possible that TGFb-1 induces cardiac myogen-
esis in epiblast by upregulation of activin expression. Alter-
natively, TGFb and activin may have redundant or overlap-
ping inductive roles in the cardiac myogenesis pathway.
BMP-2 or BMP-4, in contrast, readily induces cardiac
muscle markers in gastrula-stage anterior medial meso-
FIG. 6. Inhibition of cardiac myogenesis in posterior region explants by BMP-4 or BMP-4. (A) Stage XI–XIV posterior region explants from
chick blastoderms were explanted in control medium. Treatment was initiated at varying times following explantation by replacement of
control medium with medium containing 100 ng/ml BMP-2 or 10 ng/ml BMP-4, and the incidence of cardiac myogenesis was determined
following 72 h of culture. (B) Posterior regions from stage XI–XIV pregastrula embryos, primitive-streak heart-forming regions of stage 2–3
early to midgastrula, or anterior lateral (precardiac) mesendoderm from stage 5 late gastrula embryos were excised and explanted directly
into 100 ng/ml BMP-2 or 10 ng/ml BMP-4, cultured for 72 or 48 h, respectively, and assayed for the presence of cardiac myocytes. An
asterisk (*) denotes a value significantly different from control (P , 0.05).
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FIG. 7. Multistep signaling model of cardiac myogenesis. (A) Prior to gastrulation (stage XIII), BMP-4 is broadly expressed in the epiblast,
while activin and TGFb are expressed in pregastrula hypoblast. Antagonism of BMP-4 activity by chordin in posterior epiblast cells leads
to the onset of gastrulation (Streit et al., 1998). Reduced heart muscle-inducing capacity of anterior relative to posterior hypoblast
(Yatskievych et al., 1997) may reflect an anterior to posterior expression gradient of activin/TGFb or related molecules. (B) Specification
of myocardial precursors (specified cells shown in red) appears to commence at stage 3 while cells fated to form heart are within the
primitive streak in a broad region posterior to Hensen’s node. BMP-2 is expressed in the posterior streak at this stage. Based upon analogy
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derm (Schultheiss et al., 1997; Andre´e et al., 1998) and
when combined with FGF-4 can induce myocardial cell
formation in stage 5–6 posterior lateral mesoderm (Fig. 2B;
Lough et al., 1996). Data presented here show that BMP-2 or
BMP-4, alone or in combination with FGF-4, fails to induce
cardiac myogenesis in epiblast. BMPs, with FGF-4, can thus
mimic anterior lateral endoderm, which can convert meso-
derm to myocardial lineages but has essentially no capacity
to induce epiblast cells to form heart muscle (Yatskievych
et al., 1997). This is consistent with the localization of
BMP-2 and FGF-4 in the endoderm and BMP-4 in the
ectoderm adjacent to precardiac mesoderm at gastrula
stages (Sugi and Lough, 1995; Schultheiss et al., 1997;
Andre´e et al., 1998) and with the localization of Smad1 and
Smad5, the intracellular mediators of BMP signaling
(Yamamoto et al., 1997). Chicken Smad1 and Smad5 are
expressed during early gastrula stages within cells of the
primitive streak (L. Gont and J. Lough, personal communi-
cation) at the time when endoderm and mesoderm first
appear and myocardial cell specification commences
(Yatskievych et al., 1997).
Additional evidence that activin/TGFb signaling lies up-
stream of BMP signaling in the cardiac myogenesis pathway
was obtained using noggin and follistatin. Noggin, a specific
antagonist of BMP signaling (Piccolo et al., 1996; Zimmerman
et al., 1996), continued to block cardiac myogenesis in intact
(epiblast plus hypoblast) posterior regions until administra-
tion was delayed 36 h following explantation, a time very
close to the onset of differentiation in vitro (Yatskievych et al.,
1997). Follistatin, which antagonizes activin with 10-fold
greater efficacy than BMP activity (Nakamura et al., 1990;
Kogawa et al., 1991; Yamashita et al., 1995; Fainsod et al.,
1997), blocked appearance of cardiac myocytes only when
added up to 24 h following explantation. These results reflect
differences in vivo; noggin, but not follistatin, repressed ap-
pearance of myocardial cells in stage 5 precardiac region
explants. This repression was lost by stage 6, consistent with
previously published reports (Schultheiss et al., 1997). Noggin
was also shown to inhibit induction of cardiac myogenesis in
epiblast by activin, providing additional evidence that BMP
signaling is required downstream of activin signaling in the
cardiac myogenesis pathway. Taken together with the recip-
rocal inducing capacities of activin/TGFb and BMP-2/BMP-4,
our results support a model of cardiogenesis in which these
molecules mediate temporally and qualitatively distinct sig-
nals derived from pregastrula hypoblast acting on epiblast and
endoderm acting on emerging mesoderm, respectively.
BMPs May Play a Dual Role in Determining
Myocardial Cell Fate
In addition to the inductive role for BMP-2/BMP-4 acting on
the mesoderm in the cardiac myogenesis pathway, BMPs also
play an early inhibitory role in the epiblast. BMP-2 mRNA is
detectable by RT-PCR in the chick embryo just prior to
gastrulation (Andre´e et al., 1998), and BMP-4 is expressed
broadly in the epiblast of the pregastrula chick embryo (Streit
et al., 1998). Chordin, a natural BMP antagonist (Piccolo et al.,
1996), is expressed in the region where the primitive streak
forms and in Hensen’s node as gastrulation proceeds (Streit et
al., 1998). Ectopic expression of chordin in anterior epiblast
can induce a secondary primitive streak to form, and overex-
pression of BMP-4 can inhibit endogenous streak formation
(Streit et al., 1998), demonstrating that repression of BMP
signaling is both necessary and sufficient for streak formation.
This is consistent with our results showing that BMP-2 or
BMP-4 can block the ability of FGF-4, activin, or the hypoblast
to induce formation of cardiac myocytes in posterior region
epiblast and in heart-forming-region explants prior to stage 3.
A Signaling Cascade Regulating Cardiac
Myogenesis
These findings and other published studies suggest a
cascade leading from pregastrula epiblast to differentiated
myocardium that involves at a minimum the following
signaling interactions (Fig. 7): (1) antagonism of BMP-4
expression in epiblast by chordin in the posterior region to
initiate gastrulation; (2) induction and patterning of emerg-
ing mesoderm prior to stage 4 by activin/TGFb dorsalizing
signals, likely acting in opposition to BMP signals from
posterior primitive streak regions (Schultheiss et al., 1997;
Andre´e et al., 1998); and (3) localized expression of BMP-2
in an anterior arc of endoderm that induces expression of
genes such as cNkx2-5 and GATA-4 in overlying mesoderm
during later gastrula stages, leading to cardiac myocyte
differentiation.
to studies in amphibians, posterior BMP-2 expression may oppose anterior signals, perhaps from Hensen’s node, to generate an
anterior–posterior gradient within emerging mesoderm. While activin/TGFb may act as the anterior signaling molecules, their localization
within the embryo at this stage is unclear. Anteriorward migration of the hypoblast during gastrulation may also play a role in generating
anterior–posterior polarity in mesoderm. Anterior–posterior polarity may reflect direct activation of lineage-specific genes within emerging
mesoderm or alternatively may enable cells to respond differentially to later signals from endoderm. (C) By stage 6, precardiac mesoderm
has migrated to an anterior lateral position that is directly subtended by endoderm expressing BMP-2, which is required for activation of
genes such as cNkx2-5 and GATA-4. Additional molecules produced by the endoderm include IGF-II; insulin; FGFs 1, 2 alt-2, and 4; activin;
and vitamin A binding proteins (Barron et al., 1998). While one or more FGFs may play an inductive role in cardiac myogenesis (this paper
and Lough et al., 1996), other growth factors may stimulate survival and/or replication of precardiac mesoderm. Signals from axial
structures, likely including chordin produced by the notochord, are known to inhibit cardiac myogenesis and may help to define the heart
morphogenetic field. Abbreviation: HN; Hensen’s node.
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How do these multiple signaling processes interact to
establish the cardiogenic field? It is not clear whether
activin/TGFb and BMP signals proposed in step (2) above
would merely impart polarity to emerging mesoderm or
activate genes within specific mesodermal lineages. Activin
can induce progressively more dorsal mesodermal deriva-
tives in a dose-dependent manner in both birds and amphib-
ians (Gurdon et al., 1994; Stern et al., 1995; Jones et al.,
1996; Jones and Smith, 1998), and a recent study in Xenopus
has shown that genes reflecting different types of mesoderm
are differentially expressed based upon the absolute number
of occupied activin receptors on responsive cells (Dyson and
Gurdon, 1998). Activin is antagonized by ventral BMP
signaling in Xenopus (Candia et al., 1997; Fainsod et al.,
1997), resulting in the graded reappearance of mesoderm
along a dorsal–ventral axis. It has been proposed that
activation of the opposing activin and BMP signaling path-
ways results in competition for Smad4, the synergistic
partner required for Smad activity (Lagna et al., 1996; Shi et
al., 1997), by the downstream transducers, Smad2 and
Smad1/5, respectively (Candia et al., 1997). This competi-
tion could therefore determine the relative strengths and
antagonisms of activin/TGFb and early BMP signals, lead-
ing to the specification of particular cell fates. If activin/
TGFb and BMP signaling gradients directly activate genes
within specific mesodermal lineages in birds and mammals,
this would suggest that cardiac lineage-specific genes are
expressed upstream of cNkx2-5, prior to the migration of
precardiac mesoderm to anterior lateral regions at stage
51–6. Expression of these unknown genes could account for
the observations that specification of cardiogenic meso-
derm is under way by stage 3 (Yatskievych et al., 1998) and
possesses atrial or ventricular identity shortly after emerg-
ing from the primitive streak (Yutzey et al., 1995). Alterna-
tively, patterning of emerging precardiac mesoderm might
be reflected in differential responsiveness to a seemingly
homogeneous BMP-2 source from the anterior lateral
endoderm. Further dissection of these molecular pathways
should help distinguish between these possibilities.
ACKNOWLEDGMENTS
We thank Dr. Robert Baker and Mark Bales for their comments
on and critique of the manuscript and Dr. Robert Kuehl for
assistance with statistical analyses. This work was supported by
grants to P.B.A. from the NIH (HL54133 and HL20220) and the
American Heart Association, Arizona Affiliate. A.N.L. is a Howard
Hughes Medical Institute Predoctoral Fellow.
REFERENCES
Andre´e, B., Duprez, D., Vorbusch, B., Arnold, H-H., and Brand, T.
(1998). BMP-2 induces ectopic expression of cardiac lineage
markers and interferes with somite formation in chicken em-
bryos. Mech. Dev. 70, 119–131.
Antin, P. B., Taylor, R. G., and Yatskievych, T. A. (1994). Precardiac
mesoderm is specified during gastrulation in quail. Dev. Dyn.
200, 144–153.
Antin, P. B., Yatskievych, T. A., Luna Dominguez, J., and Chieffi,
P. (1996). Regulation of avian precardiac mesoderm development
by insulin and insulin-like growth factors. J. Cell. Physiol. 168,
42–50.
Barron, M., McAllister, D., Smith, S. M., and Lough, J. (1998).
Expression of retinol binding protein and transthyretin during
early embryogenesis. Dev. Dyn. 212, 413–422.
Candia, A. F., Watabe, T., Hawley, S. H. B., Onichtchouk, D.,
Zhang, Y., Derynck, R., Niehrs, C., and Cho, K. W. Y. (1997).
Cellular interpretation of multiple TGF-b signals: Intracellular
antagonism between activin/BVg1 and BMP-2/4 signaling medi-
ated by Smads. Development 124, 4467–4480.
DeHaan, R. L. (1963a). Migration patterns of the precardiac meso-
derm in the early chick embryo. Exp. Cell Res. 29, 544–560.
DeHaan, R. L. (1963b). Organization of the cardiogenic plate in the
early chick embryo. Acta Embryol. Morphol. Exp. 6, 26–38.
Dyson, S., and Gurdon, J. B. (1998). The interpretation of position in
a morphogen gradient as revealed by occupancy of activin recep-
tors. Cell 93, 557–568.
Eyal-Giladi, H., and Kochav, S. (1976). From cleavage to primitive
streak formation: A complementary normal table and a new look
at the first stages of the development of the chick. Dev. Biol. 49,
321–337.
Fainsod, A., Deissler, K., Yelin, R., Marom, K., Epstein, M.,
Pillemar, G., Steinbeisser, H., and Blum, M. (1997). The dorsal-
izing and neural inducing gene follistatin is an antagonist of
BMP-4. Mech. Dev. 63, 39–50.
Gannon, M., and Bader, D. (1995). Initiation of cardiac differentia-
tion occurs in the absence of anterior endoderm. Development
121, 2439–2450.
Garcia-Martinez, V., and Schoenwolf, G. C. (1993). Primitive-
streak origin of cardiovascular system in avian embryos. Dev.
Biol. 159, 706–719.
Gonza´lez-Sanchez, A., and Bader, D. (1990). In vitro analysis of
cardiac progenitor cell differentiation. Dev. Biol. 139, 197–209.
Graff, J. M., Bansal, A., and Melton, D. A. (1996). Xenopus Mad
proteins transduce distinct subsets of signals for the TGFb
superfamily. Cell 85, 479–487.
Green, J. B. A., New, H. V., and Smith, J. C. (1992). Responses of
embryonic Xenopus cells to activin and FGF are separated by
multiple dose thresholds and correspond to distinct axes of the
mesoderm. Cell 71, 731–739.
Gurdon, J. B., Harger, P., Mitchell, A., and Lemaire, P. (1994).
Activin signalling and response to a morphogen gradient. Nature
371, 487–492.
Hamburger, V., and Hamilton, H. L. (1951). A series of normal
stages in the development of the chick embryo. J. Morphol. 88,
49–92.
Hatada, Y., and Stern, C. D. (1994). A fate map of the epiblast of the
early chick embryo. Development 120, 2879–2889.
Jones, C. M., Armes, N., and Smith, J. C. (1996). Signalling by
TGF-b family members: Short-range effects of Xnr-2 and BMP-4
contrast with the long-range effects of activin. Curr. Biol. 6,
1468–1475.
Jones, C. M., and Smith, J. C. (1998). Establishment of a BMP-4
morphogen gradient by long-range inhibition. Dev. Biol. 194,
12–17.
Kogawa, K., Nakamura, T., Sugino, K., Takio, K., Titani, K., and
Sugino, H. (1991). Activin-binding protein is present in pituitary.
Endocrinology 128, 1434–1440.
Kokan-Moore, M. P., Bolender, D. L., and Lough, J. (1991). Secretion
of inhibin bA by endoderm cultured from early embryonic
chicken. Dev. Biol. 146, 242–245.
418 Ladd, Yatskievych, and Antin
Copyright © 1998 by Academic Press. All rights of reproduction in any form reserved.
Lagna, G., Hata, A., Hemmati-Brivanlou, A., and Massague, J.
(1996). Partnership between DPC4 and SMAD proteins in TGF-
b_signaling pathways. Nature 383, 832–836.
Logan, M., and Mohun, T. (1993). Induction of cardiac muscle
differentiation in isolated animal pole explants of Xenopus laevis
embryos. Development 118, 865–875.
Lough, J., Barron, M., Brogley, M., Sugi, Y., Bolender, D. L., and
Zhu, X. (1996). Combined BMP-2 and FGF-4, but neither factor
alone, induces cardiogenesis in nonprecardiac embryonic meso-
derm. Dev. Biol. 178, 198–202.
Mitrani, E., Ziv, T., Thomsen, G., Shimoni, Y., Melton, D. A., and
Bril, A. (1990). Activin can induce the formation of axial struc-
tures and is expressed in the hypoblast of the chick. Cell 63,
495–501.
Montgomery, M. O., Litvin, J., Gonzalez-Sanchez, A., and Bader, D.
(1994). Staging of commitment and differentiation of avian
cardiac myocytes. Dev. Biol. 164, 63–71.
Nakamura, T., Takio, K., Eto, Y., Shibai, H., Titani, K., and Sugino,
H. (1990). Activin-binding protein from rat ovary is follistatin.
Science 247, 836–838.
Nakao, A., Imamura, T., Souchelnytskyi, S., Kawabata, M., Ish-
isaki, A., Oeda, E., Tamaki, K., Hanai, J., Heldin, C. H., Miya-
zono, K., and ten Dijke, P. (1997). TGF-beta receptor-mediated
signalling through Smad2, Smad3 and Smad4. EMBO J. 16(17),
5353–5362.
Nascone, N., and Mercola, M. (1995). An inductive role for the
endoderm in Xenopus cardiogenesis. Development 121, 515–523.
Orts-Llorca, F. (1963). Influence of the endoderm on heart differen-
tiation during the early stages of development of the chick
embryo. Wilhelm Roux Arch. Entw. Mech. Org. 154, 533–551.
Orts-Llorca, F., and Gil, R. D. (1965). Influence of the endoderm on
heart differentiation. Wilhelm Roux Arch. Entw. Mech. Org. 156,
368–370.
Parlow, M. H., Bolender, D. L., Kokan-Moore, N. P., and Lough, J.
(1991). Localization of bFGF-like protein as punctate inclusions
in the preseptation myocardium. Dev. Biol. 146, 139–147.
Piccolo, S., Sasai, Y., Lu, B., and De Robertis, E.M. (1996). Dorso-
ventral patterning in Xenopus: Inhibition of ventral signals by
direct binding of chordin to BMP-4. Cell 86, 589–598.
Rawles, M.E. (1943). The heart-forming regions of the early chick
blastoderm. Physiol. Zool. 16, 22–42.
Rosa, F., Roberts, A. B., Danielpour, D., Dart, L. L., Sporn, M. B.,
and Dawid, I. B. (1988). Mesoderm induction in amphibians: The
role of TGF-b2-like factors. Nature 239, 783–785.
Rosenquist, G. C. (1966). A radioautographic study of labeled grafts
in the chick blastoderm. Development of primitive-streak stages
to stage 12. Carnegie Inst. Wash. Publ. 625, Contrib. Embryol.
38, 111–121.
Sanders, E. J., Prasad, S., and Hu, N. (1993). The involvement of
TGFb1 in early avian development: gastrulation and chondro-
genesis. Anat. Embryol. 187, 573–581.
Sanders, E. J., Hu, N., and Wride, M. A. (1994). Expression of
TGFb1/b3 during early chick embryo development. Anat. Rec.
238, 397–406.
Sater, A. K., and Jacobson, A. G. (1990). The role of the dorsal lip in
the induction of heart mesoderm in Xenopus laevis. Develop-
ment 108, 461–470.
Schultheiss, T. M., Burch, J. B. E., and Lassar, A. B. (1997). A role for
bone morphogenetic proteins in the induction of cardiac myo-
genesis. Genes Dev. 11, 451–462.
Schultheiss, T. M., Xydas, S., and Lasssar, A. B. (1995). Induction of
avian cardiac myogenesis by anterior endoderm. Development
121, 4203–4214.
Shi, Y., Hata, A., Lo, R. S., Massague, J., and Pavletich, N. P. (1997).
A structural basis for mutational inactivation of the tumor
suppressor Smad4. Nature 388, 87–93.
Smith, W. C., and Harland, R. M. (1992). Expression cloning of
noggin, a new dorsalizing factor localized to the Spemann orga-
nizer in Xenopus embryos. Cell 70,829–840.
Stern, C. D., Yu, R. T., Kakizuka, A., Kintner, C. R., Mathews,
L. S., Vale, W. W., Evans, R. M., and Umesono, K. (1995).
Activin and its receptors during gastrulation and the later
phases of mesoderm development in the chick embryo. Dev.
Biol. 172, 192–205.
Streit, A., Lee, K. J., Woo, I., Roberts, K., Jessell, T. M., and Stern,
C. D. (1998). Chordin regulates primitive streak development
and the stability of induced neural cells, but is not sufficient for
neural induction in the chick embryo. Development 125, 507–
519.
Sugi, Y., and Lough, J. (1995). Activin-A and FGF-2 mimic the
inductive effects of anterior endoderm on terminal cardiac myo-
genesis in vitro. Dev. Biol. 168, 567–574.
Sugi, Y., Sasse, J., and Lough, J. (1993). Inhibition of precardiac
mesoderm cell proliferation by antisense oligodeoxynucleotide
complementary to fibroblast growth factor-2 (FGF-2). Dev. Biol.
157, 19–27.
van der Kruijssen, C. M. M., Feijen, A., Huylebroeck, D., and van
der Eijnden-van Raaij, A. J. M. (1993). Modulation of activin
expression by type b transforming growth factors. Exp. Cell Res.
207, 407–412.
Yamamoto, N., Akiyama, S., Katagiri, T., Namiki, M., Kurokawa,
T., and Suda, T. (1997). Smad1 and Smad5 act downstream of
intracellular signaling of BMP-2 that inhibits myogenic differen-
tiation and induces osteoblast differentiation in C2C12 myo-
blasts. Biochem. Biophys. Res. Commun. 238, 574–580.
Yamashita, H., ten Dijke, P., Huylebroeck, D., Sampath, T. K.,
Andries, M., Smith, J. C., Heldin, C-H., and Miyazono, K. (1995).
Osteogenic protein-1 binds to activin type II receptors and
induces certain activin-like effects. J. Cell Biol. 130, 217–226.
Yatskievych, T. A., Ladd, A. N., and Antin, P. B. (1997). Induction
of cardiac myogenesis in avian pregastrula epiblast: The role of
the hypoblast and activin. Development 124, 2561–2570.
Zhu, X., Sasse, J., McAllister, D., and Lough, J. (1996). Evidence that
fibroblast growth factors 1 and 4 participate in regulation of
cardiogenesis. Dev. Dyn. 207, 429–438.
Zimmerman, L. B., de Jesus-Escobar, J. M., and Harland, R. M.
(1996). The Spemann organizer signal noggin binds and inacti-
vates bone morphogenetic protein 4. Cell 86, 599–606.
Received for publication June 25, 1998
Revised September 21, 1998
Accepted September 21, 1998
419Growth Factor Regulation of Cardiac Myogenesis
Copyright © 1998 by Academic Press. All rights of reproduction in any form reserved.
